Zepbound Injection(Tirzepatide) 10mg/0.5ml

Zepbound contains tirzepatide, a GIP and GLP-1 receptor agonist used in combination with a reduced-calorie diet and increased physical activity to support weight reduction and long-term weight maintenance in eligible adults with obesity or overweight with at least one weight-related health condition. It is administered by subcutaneous injection once weekly as prescribed by a healthcare professional.

Key Features & Specifications

• Active ingredient: Tirzepatide
• Medicine class: GIP and GLP-1 receptor agonist
• Administration: Subcutaneous injection
• Frequency: Once weekly
• Available strengths: 2.5 mg–15 mg
• Primary use: Weight reduction and long-term weight maintenance
• Manufacturer: Eli Lilly
• Prescription: Yes